Lateral flow validation prioritisation criteria for rapid diagnostic assays for specific SARS-CoV-2 antigens, DHSC (updated 6th April 2021)

An overview of the future requirements for rapid COVID-19 diagnostic assays for antigen lateral flow devices. 6 April 2021Updates to the self-testing section with links to more detail on the CE mark, UKCA mark and MHRA exemptions from medical devices regulations. 5 March 2021Update on sample types required for validation of lateral flow devices.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news